Head and neck cancers are a heterogeneous, aggressive and genetically complex
collection of malignancies of the oral cavity, nasopharynx, oropharynx, hypopharynx, larynx …

Head and neck squamous cell carcinomas (HNSCCs) are an aggressive, genetically
complex and difficult to treat group of cancers. In lieu of truly effective targeted therapies …

Despite improvements in functional outcomes attributable to advances in radiotherapy,
chemotherapy, surgical techniques, and imaging techniques, survival in head and neck …

Head and neck squamous cell carcinoma (HNSCC) is one of the most common types of
human cancer, with an annual incidence of more than 500,000 cases worldwide. In the …

Head and neck cancer consists of a diverse group of cancers that ranges from cutaneous,
lip, salivary glands, sinuses, oral cavity, pharynx and larynx. Each group dictates different …

The 20th century saw great advances in anatomy‐based (surgery and radiotherapy) and
chemotherapy approaches for treating head and neck squamous cell carcinoma (HNSCC) …

Simple Summary Head and neck cancer (HNC) incidence has been steadily increasing
since the 1990s. While the multimodal treatment approach for localized HNC is well …

Head and neck cancers include neoplasms of the oral cavity, pharynx, and larynx. The risk
of these cancers is strongly associated with smoking and alcohol ingestion. There have …

There are more than half a million incident cases of squamous-cell carcinoma of the head
and neck worldwide each year, primarily affecting the oropharynx, oral cavity, hypopharynx …

Head and neck squamous cell carcinoma (HNSCC) is the sixth most incident cancer
worldwide. More than half of HNSCC patients experience locoregional or distant relapse to …